Milton Boyer
Chief Executive Officer
Chief Executive Officer
DCAT
Russian Federation
Biography
Mr. Boyer is the chief executive officer at SCA Pharmaceuticals. Formerly he was senior vice president and business unit head of the Drug Product Division at AMRI. He joined AMRI in 2014 upon the acquisition of OSO BioPharmaceuticals where he served as president and CEO and was also a member of the Board of Directors. For the past 18 years, his assignments have been focused in contract manufacturing for both pharmaceuticals and biopharmaceuticals, developing experience and expertise for both drug substance and drug product. He holds a B.S. in Chemistry/Physics and an M.S. in Biochemistry. Mr. Boyer is very active in trade groups and educational institutions that support the pharmaceutical and biopharmaceutical industry. In addition to DCAT, he currently serves on the External Advisory Board for the Department of Chemistry and Biology for the University of New Mexico. He has also been a member of other professional organizations, including the American Association of Pharmaceutical Scientists (AAPS), International Society of Pharmaceutical Engineers (ISPE) and the Parenteral Drug Association (PDA).
Research Interest
Mr. Boyer is the chief executive officer at SCA Pharmaceuticals. Formerly he was senior vice president and business unit head of the Drug Product Division at AMRI. He joined AMRI in 2014 upon the acquisition of OSO BioPharmaceuticals where he served as president and CEO and was also a member of the Board of Directors. For the past 18 years, his assignments have been focused in contract manufacturing for both pharmaceuticals and biopharmaceuticals, developing experience and expertise for both drug substance and drug product. He holds a B.S. in Chemistry/Physics and an M.S. in Biochemistry. Mr. Boyer is very active in trade groups and educational institutions that support the pharmaceutical and biopharmaceutical industry. In addition to DCAT, he currently serves on the External Advisory Board for the Department of Chemistry and Biology for the University of New Mexico. He has also been a member of other professional organizations, including the American Association of Pharmaceutical Scientists (AAPS), International Society of Pharmaceutical Engineers (ISPE) and the Parenteral Drug Association (PDA).
